Biolife Solutions Inc financial data

Symbol
BLFS on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
3303 Monte Villa Parkway, Suite 310, Bothell, WA
State of incorporation
DE
Fiscal year end
December 31
Former names
CRYOMEDICAL SCIENCES INC (to 11/14/2002)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 285 % -2.39%
Quick Ratio 97.6 % +6.98%
Debt-to-equity 19.2 % -19.3%
Return On Assets -11.7 % +50.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 46.4M shares +5.35%
Common Stock, Shares, Outstanding 46.2M shares +5.47%
Entity Public Float 774M USD +63.7%
Common Stock, Value, Issued 46K USD +4.55%
Weighted Average Number of Shares Outstanding, Basic 46.2M shares +5.98%
Weighted Average Number of Shares Outstanding, Diluted 46.2M shares +5.98%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 15.1M USD -4.86%
Selling and Marketing Expense 21.5M USD +1.68%
General and Administrative Expense 51.7M USD -0.11%
Costs and Expenses 189M USD -15.5%
Operating Income (Loss) -45.6M USD +48.8%
Nonoperating Income (Expense) -4.8M USD -198%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -50.4M USD +40.1%
Income Tax Expense (Benefit) 63K USD -124%
Net Income (Loss) Attributable to Parent -46M USD +55%
Earnings Per Share, Basic -1.01 USD/shares +57.4%
Earnings Per Share, Diluted -1.01 USD/shares +94%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24M USD +24.7%
Cash, Cash Equivalents, and Short-term Investments 39.3M USD -6.87%
Accounts Receivable, after Allowance for Credit Loss, Current 17.9M USD -27%
Inventory, Net 32.2M USD -25.8%
Assets, Current 89.4M USD -23.5%
Property, Plant and Equipment, Net 17.7M USD -15.7%
Operating Lease, Right-of-Use Asset 14.4M USD +13.8%
Intangible Assets, Net (Excluding Goodwill) 18.4M USD -16.5%
Goodwill 225M USD 0%
Assets 382M USD -7.18%
Accounts Payable, Current 3.84M USD -68%
Accrued Liabilities, Current 2.86M USD -22.7%
Contract with Customer, Liability, Current 435K USD -34.1%
Liabilities, Current 32.2M USD -24.5%
Deferred Income Tax Liabilities, Net 100K USD -65%
Operating Lease, Liability, Noncurrent 15.2M USD +11.1%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 56.2M USD -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax -208K USD +68.5%
Retained Earnings (Accumulated Deficit) -348M USD -15.9%
Stockholders' Equity Attributable to Parent 325M USD -1.98%
Liabilities and Equity 382M USD -7.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.48M USD -65%
Net Cash Provided by (Used in) Financing Activities -952K USD -69.4%
Net Cash Provided by (Used in) Investing Activities -221K USD -108%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 46.2M shares +5.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.2M USD +25.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 445K USD -10.5%
Deferred Tax Assets, Valuation Allowance 54.7M USD +36.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 56M USD +26.1%
Operating Lease, Liability 18M USD +8.41%
Depreciation 2.8M USD -23.1%
Payments to Acquire Property, Plant, and Equipment 3.3M USD +126%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.6M USD +55.2%
Lessee, Operating Lease, Liability, to be Paid 21.5M USD +13.4%
Property, Plant and Equipment, Gross 27.9M USD -7.96%
Operating Lease, Liability, Current 2.79M USD -4.06%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.25M USD +10.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.63M USD +7.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +46.5%
Deferred Income Tax Expense (Benefit) 5K USD -61.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.54M USD +47.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.97M USD +17.3%
Deferred Tax Assets, Operating Loss Carryforwards 35.5M USD +22%
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 954K USD +56.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.02M USD +32.5%
Additional Paid in Capital 653M USD
Amortization of Intangible Assets 3.74M USD -33.7%
Depreciation, Depletion and Amortization 1.36M USD -20.7%
Share-based Payment Arrangement, Expense 27.6M USD -4.12%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%